EOLS
HEALTHCAREEvolus Inc
$6.32-0.05 (-0.78%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving EOLS Today?
No stock-specific AI insight has been generated for EOLS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.86$10.62
$6.32
Fundamentals
Market Cap$421M
P/E Ratio—
EPS$-0.66
Dividend Yield—
Dividend / Share—
ROE-187.3%
Profit Margin-0.1%
Debt / Equity—
Trading
Volume1.5M
Avg Volume (10D)—
Shares Outstanding65.9M
EOLS News
20 articles- Evolus, Inc. Q1 2026 Earnings Call SummaryMoby·May 5, 2026
- Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 4, 2026
- Evolus Q1 Earnings Call HighlightsMarketbeat·May 4, 2026
- Evolus (EOLS) Q2 2025 Earnings Call TranscriptMotley Fool·May 4, 2026
- Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year OutlookYahoo Finance·May 4, 2026
- How The Evolus (EOLS) Story Is Shifting As Analysts Reset Growth And Valuation AssumptionsYahoo Finance·Apr 26, 2026
- April 2026's Leading Growth Stocks With Insider ConfidenceYahoo Finance·Apr 16, 2026
- Evolus Targets Double-Digit Growth, Full-Year Profitability at Needham Healthcare ConferenceMarketbeat·Apr 16, 2026
- Evolus to Report First Quarter Financial Results on May 4, 2026Yahoo Finance·Apr 14, 2026
- How The Evolus (EOLS) Investment Story Is Shifting After Softer Guidance And Target CutsYahoo Finance·Apr 11, 2026
- Revance CEO Nadeem Moiz on Expansion, Opportunities & CapitalizationYahoo Finance·Apr 7, 2026
- Telix Appoints David Gill as Non-Executive DirectorYahoo Finance·Apr 1, 2026
- Evolus to Participate in the Needham 25th Annual Virtual Healthcare ConferenceYahoo Finance·Mar 31, 2026
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·Mar 20, 2026
- Evolus Sees Toxin Market Stabilizing, Evolysse Gaining Traction, Raises 2028 Revenue Targets at ConferenceMarketbeat·Mar 15, 2026
- How The Narrative On Evolus (EOLS) Is Resetting After Cautious 2025 And 2026 GuidanceYahoo Finance·Mar 12, 2026
- Why Evolus Stock Soared TodayMotley Fool·Mar 5, 2026
- Evolus, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 4, 2026
- Evolus Inc (EOLS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market ChallengesYahoo Finance·Mar 4, 2026
- Evolus Q4 Earnings Call HighlightsMarketbeat·Mar 4, 2026
All 20 articles loaded
Price Data
Open$6.47
Previous Close$6.37
Day High$6.70
Day Low$6.27
52 Week High$10.62
52 Week Low$3.86
52-Week Range
$3.86$10.62
$6.32
Fundamentals
Market Cap$421M
P/E Ratio—
EPS$-0.66
Dividend Yield—
Dividend / Share—
ROE-187.3%
Profit Margin-0.1%
Debt / Equity—
Trading
Volume1.5M
Avg Volume (10D)—
Shares Outstanding65.9M
About Evolus Inc
Evolus, Inc., a high-performance beauty company, provides aesthetic medical products for physicians and their patients in the United States. The company is headquartered in Newport Beach, California.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—